An effector from the Huanglongbing-associated pathogen targets citrus proteases
Kelley Clark1, Jessica Yvette Franco2, Simon Schwizer1,3
1Department of Microbiology and Plant Pathology, University of California, Riverside, 92521, CA, USA.
Nature Communications
|May 2, 2018
Summary
Huanglongbing (HLB) threatens citrus crops. Researchers found that a bacterial protein, SDE1, inhibits citrus proteases involved in plant defense, offering new insights into HLB virulence and potential management strategies.
Area of Science:
- Plant Pathology
- Molecular Biology
- Agricultural Science
Background:
- Huanglongbing (HLB) is a devastating citrus disease caused by 'Candidatus Liberibacter asiaticus' (CLas).
- There is currently no known resistance to HLB in citrus cultivars.
- Understanding HLB pathogenesis is critical for developing effective disease management strategies.
Purpose of the Study:
- To investigate the role of Sec-delivered effector 1 (SDE1) in CLas virulence.
- To elucidate the molecular mechanisms by which CLas affects citrus plants.
- To identify potential targets for HLB control.
Main Methods:
- Utilized SDE1 as a molecular probe to study CLas virulence.
- Investigated the interaction between SDE1 and citrus papain-like cysteine proteases (PLCPs).
- Analyzed PLCP activity in CLas-infected citrus and SDE1-expressing transgenic citrus.
Main Results:
- SDE1 directly interacts with and inhibits the activity of citrus PLCPs.
- PLCPs are defense-inducible and increase in abundance during CLas infection.
- SDE1 expression in citrus leads to reduced PLCP activity, indicating SDE1's role in suppressing plant defenses.
Conclusions:
- SDE1 is a key virulence factor of CLas that inhibits citrus immune-related proteases (PLCPs).
- Inhibition of PLCPs by SDE1 likely contributes to HLB pathogenesis by suppressing plant defense responses.
- Targeting the SDE1-PLCP interaction could be a novel strategy for HLB management.
More Related Videos
Related Concept Videos
Defenses Against Pathogens and Herbivores
29.7K
Plants present a rich source of nutrients for many organisms, making it a target for herbivores and infectious agents. Plants, though lacking a proper immune system, have developed an array of constitutive and inducible defenses to fend off these attacks.
29.7K
Defense Against Bacterial Pathogens
2.9K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.9K
Immune Response Against Viral Pathogens
2.1K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.1K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Targets for Drug Action: Overview
10.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.5K
Target Cell Response to Hormones
5.8K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.8K


